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Any of the 42 health ministers attending 
the Global Ministerial Forum on 
Research for Health in Bamako, Mali, 
last year, who failed to push through 
laws for ethical research within a year, 
should be excluded from all future 
assemblies.
This was proposed by Dr Mohamad 
Hassar, director of Morocco’s Pasteur 
Institute, who declared himself fed up 
with woolly policy proposals that ‘never 
went anywhere’,  politically.
Hassar was speaking from the floor 
during a session aimed at promoting 
research for health by earning public 
trust through ethics and social justice. 
His proposal failed to make it into 
the distilled ‘Bamako Call to Action’ 
Declaration made on the final day of the 
conference.
Hassar’s view of the forum’s efficacy 
was cynical compared with that of Dr 
Timothy Evans, the WHO’s Assistant 
Director-General for Information, 
Evidence and Research and the former 
Director for Health Equity at the 
Rockefeller Foundation.
Evans told Izindaba that the Forum, 
now in its third manifestation over 12  
years (Bangkok and Mexico previously), 
was the ‘ideal vehicle’ for engaging and 
addressing politicians, who for example 
supported damaging denial of key 
scientific evidence. He was speaking 
in the context of the AIDS denialism 
and political heel dragging in South 
Africa until the dramatic cabinet and 
presidential turnaround in September 
last year. 
South Africa’s new health minister, 
Barbara Hogan, did not attend the 
Bamako Forum as she was already 
committed to an international 
gathering on tobacco control in Cape 
Town.  A high-level delegation from 
her department did, however, along 
with a host of senior figures from the 
country’s major research institutions 
and universities.
Dr Hassar said it was time to act 
on legislation for ethical research. ‘We 
know what has to be done … there are 
several reports by the WHO, UNESCO 
… all countries should commit to 
passing legislation on ethics within one 
year or leave this world assembly of 
ministers of health.  A country without 
such laws cannot claim to share our 
values. Such values have to be enacted 
to protect the population,’ he said.
Commercial, not public interest 
driving research
Speaker after speaker in the session 
highlighted the burgeoning increase 
in commercial research driven by the 
hunger for new marketable technologies 
and of how few research subjects 
actually benefited from them.
 Asia and Africa emerged as the two 
main target countries for commercial 
outfits that set up their own ethics 
committees wherever legislation was 
lacking.  
Dr Aissatou Toure, chief of the 
immunology unit at the Pasteur 
Institute in Dakar, Senegal, said 
the theory of fundamental ethics of 
respect, informed and quality consent, 
autonomy, dignity, risk-benefit analyses 
and justice was seldom carried over into 
practice.
‘For example, on the ground, if you 
simplify consent too much you end up 
with imprecision and misinformation, 
never mind the problems with scientific 
language and the translation and 
conceptual differences in spoken 
language.’
Socio-economic circumstances, 
hierarchical systems and respect for 
the authority of knowledge created 
an ethical minefield that could be 
ruthlessly manipulated without a 
government that had the political will to 
pass protective laws.
Dr Amar Jasani, of the Indian Journal 
of Medical Ethics, said protection was 
needed ‘from the tyranny of sponsors 
and collaborators’. 
In India lax regulations, low costs 
of clinical trials, large numbers 
of treatment-naïve patients and 
easily available scientific human 
resources with a large urban hospital 
infrastructure led to commercial 
research organisations burgeoning from 
a handful in 1995 to over 70 in 2005.
A lack of guidelines on compensation 
for research injuries meant that not 
a single person in India had been 
compensated (in spite of researchers 
being covered by insurance) for the past 
5 years.
‘Too many countries have 
decentralised structures to the extent 
that governments have offloaded 
responsibility – instead the commercial 
institutions determine who is appointed 
or replaced and provide the resources 
for the ethical committees,’ Jasani 
added.
Describing this as a ‘very, very 
dangerous practice’, he said committee 
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members were often not aware of 
international best practice and had 
insufficient training.
It was ‘essential’ that the legal 
regulatory authority for research 
was integrated with ethics review 
committees through legislation so 
that policies and laws provided real 
power to independent ethics review 
committees.
Single-governance mechanism 
vital
Both private commercial ethics 
committees and market research 
organisations needed to fall under 
a single governance mechanism 
complemented by an accreditation body.
Jasani said that often the ethical 
guidelines of commercial outfits were 
‘totally different to ours – they ask us 
what the issues are and then promise 
to “take care” of them – I’ve been quite 
horrified sitting on the technical review 
committee’.
He called for regulators in developed 
countries to rigorously examine proof 
of ethical conduct for clinical trials in 
developing countries.
Questioning how pharmaceutical 
companies obtained marketing 
clearance without proof of post-
trial benefits to participants and 
communities, Jasani said many 
companies were using guidelines from 
the 2000 Helsinki Declaration, simply 
because these were included in their 
laws, and not the updated versions.
Professor Jerome Singh, head of ethics 
and health law at the Centre for the 
AIDS Programme of Research in South 
Africa (Caprisa), said post-apartheid 
South Africa had made great strides to 
correct a racially skewed and unethical 
human research agenda.
Backed by several major statutory 
bodies there was a strong human 
rights culture via the Constitution that 
included a clause on ethical research 
and regular use of independent 
judicial review to check questionable 
commercial or government behaviour.
The Wisdom of Whores
Elizabeth Pisani, an epidemiologist and 
consultant working with HIV/AIDS 
in Asia and controversial author of 
The Wisdom of Whores, said too many 
researchers hid behind the rights of the 
individual to hoard data and prevent 
their use for the wider public good. 
While protecting individual rights 
was a welcome ‘step forward’ from 
a decade ago, researchers spent too 
much time and effort ‘obsessing about 
this’, while forgetting that the point 
of research was to benefit the largest 
number of people.
Unlike public health, almost every 
other field of science was moving 
towards an open data policy, she said, 
citing physicists and geneticists as 
leading the way.
‘One of the fig leaves we use in 
protecting the culture of data-hoarding 
is this idea that if we share it we’ll 
somehow be compromising the rights 
of individuals and/or confidentiality 
– there’s actually little evidence that this 
is ever the case.’
‘We shut down Beijing to ensure that 
SARS didn’t become a global pandemic 
and there are numerous examples in 
XDR TB. We do have to make the point 
that it’s unethical to collect data from 
people and not do anything with it,’ 
Pisani argued.
She gave the example of her 
accompanying a government research 
team through Djakarta’s red-light 
district when an influential and very 
angry local pimp confronted them with 
a pile of T-shirts given to his workers by 
researchers.
‘He said we take a half hour of the 
girls’ time doing incredibly invasive 
things and never do shit with the 
information – and they got nothing out 
of it but stupid T-shirts.’
Pisani grabbed headlines in 
South Africa when she accused the 
Treatment Action Campaign (TAC) of 
bias towards AIDS treatment at the 
expense of creating a market for HIV 
prevention. The TAC said she was being 
‘reductionist’.
Asked to suggest a practical way 
of addressing her concerns, she said 
ethical review boards should insist that 
data from research be used for public 
health. Review criteria should include 
quizzing researchers as to how they 
would translate their data into a public 
health benefit.
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